15 states sue Trump administration over changes to U.S. vaccine schedule
2026-02-25 07:19:21 ET
More on Pfizer, Merck, etc.
- Merck: Why Investors Should Remain Bullish Despite Patent Risks
- Pfizer: A Risky 6.3% Yield For Income-Oriented Investors
- Q4 Healthcare Dividends: Johnson & Johnson Kept Outshining Pfizer (Rating Upgrades)
- GSK to acquire Canada's 35Pharma for $950M in cash
- Merck shares advanced for seven consecutive sessions
Read the full article on Seeking Alpha
For further details see:
15 states sue Trump administration over changes to U.S. vaccine scheduleNASDAQ: SNY
SNY Trading
-0.77% G/L:
$43.65 Last:
933,628 Volume:
$43.90 Open:



